Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission
- PMID: 29271716
- DOI: 10.3171/2017.6.JNS17635
Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission
Abstract
OBJECTIVESuccessful transsphenoidal surgery for adrenocorticotropin hormone (ACTH)-producing pituitary tumors is associated with subnormal postoperative serum cortisol levels, which may guide decisions regarding immediate reoperation. However, little is known about the detailed temporal course of changes in serum cortisol in the immediate postoperative period, and the relationship of postoperative cortisol dynamics to remission and late recurrence.METHODSA single-center retrospective cohort analysis was performed for all patients undergoing pituitary surgery from 2007 through 2015. Standardized diagnostic and treatment algorithms were applied to all patients with potential Cushing's disease (CD), including microsurgical transsphenoidal adenomectomy (TSA) by a single surgeon. All patients had serum cortisol levels drawn at 6-hour intervals for 72 hours after surgery, and were offered reoperation within 3 days for normal or supranormal postoperative cortisol levels. Primary outcomes were 6-month remission and late recurrence; secondary outcomes were persistent postoperative hypocortisolism and surgical morbidity. Discriminatory levels of postoperative serum cortisol for predicting remission were calculated at various intervals after surgery using receiver operating characteristic (ROC) curves.RESULTSAmong 89 patients diagnosed with CD, 81 underwent initial TSA for a potentially curable lesion; 23 patients (25.8%) underwent an immediate second TSA. For the entire cohort, 6-month remission was achieved in 77.8% and late recurrences occurred in 9.5%, at a mean of 43.5 months. Compared with patients with a single surgery, those with an immediate second TSA had similar rates of remission (78.3% vs 77.6%) and late recurrence (5.6% vs 11.1%). The rate of hypocortisolism for patients with 2 surgeries (12/23, 52.2%) was significantly greater than that for patients with single surgeries (13/58, 22.4%; p < 0.001). There was no difference in the incidence of CSF leaks between the first and second operations. Remission was achieved in 58 (92.1%) of 64 patients who completed the 2-surgery protocol. The temporal course of postoperative serum cortisol levels among patients varied considerably, with subnormal nadir levels < 2 μg/dl occurring between 12 hours and 66 hours. Patients achieving remission had significantly lower mean serum cortisol levels at every time point after surgery (p < 0.01). By ROC curve analysis, nadir cortisol levels < 2.1 μg/dl were predictive of 6-month remission for the entire cohort over 3 days (positive predictive value [PPV] = 94%); discriminating cortisol levels for predicting remission on postoperative day (POD) 2 were < 5.4 μg/dl (PPV = 97%), although patients with remission after postoperative cortisol levels of 2-5 μg/dl had a significantly higher rate of late recurrence.CONCLUSIONSThere is substantial variation in the temporal course of serum cortisol levels over the first 72 hours after TSA for CD, with nadir levels predictive for remission occurring as late as POD 3. Although a cortisol level of 2.1 μg/dl at any point was an accurate predictor of 6-month remission, levels less than 5.4 μg/dl on POD 2 were reasonably accurate. These data may enable decisions regarding the efficacy of an immediate second surgical procedure performed during the same hospitalization; immediate reoperation is associated with excellent remission rates and low recurrence rates in patients otherwise unlikely to achieve remission, but carries a higher risk of permanent hypocortisolism.
Keywords: ACTH = adrenocorticotropin hormone; AUC = area under the curve; BIPSS = bilateral inferior petrosal sinus sampling; BMI = body mass index; CD = Cushing’s disease; CST = cosyntropin stimulation test; Cushing’s disease; NPV = negative predictive value; PACS = picture archiving and communication system; POD = postoperative day; PPV = positive predictive value; ROC = receiver operating characteristic; TSA = transsphenoidal adenomectomy; UFC = urinary free cortisol; late recurrence; pituitary surgery; postoperative cortisol; remission; reoperation; transsphenoidal surgery.
Similar articles
-
Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.Pituitary. 2013 Dec;16(4):452-8. doi: 10.1007/s11102-012-0455-z. Pituitary. 2013. PMID: 23242860
-
The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing's disease after transsphenoidal surgery.J Clin Endocrinol Metab. 2011 Jul;96(7):2057-64. doi: 10.1210/jc.2011-0456. Epub 2011 Apr 20. J Clin Endocrinol Metab. 2011. PMID: 21508126 Free PMC article.
-
Evaluation of Cushing's disease remission after transsphenoidal surgery based on early serum cortisol dynamics.Clin Endocrinol (Oxf). 2014 Mar;80(3):411-8. doi: 10.1111/cen.12300. Epub 2013 Sep 4. Clin Endocrinol (Oxf). 2014. PMID: 23895112
-
Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.J Neurosurg. 2018 Nov 1;129(5):1260-1267. doi: 10.3171/2017.5.JNS162901. J Neurosurg. 2018. PMID: 29219752 Review.
-
Neurosurgical treatment of Cushing disease in pediatric patients: case series and review of literature.Childs Nerv Syst. 2019 Nov;35(11):2127-2132. doi: 10.1007/s00381-018-4013-5. Epub 2018 Nov 28. Childs Nerv Syst. 2019. PMID: 30488233 Review.
Cited by
-
Predictive factors for recurrence of Cushing's disease after pituitary surgery.Tunis Med. 2022 Decembre;100(12):843-846. Tunis Med. 2022. PMID: 37551534 Free PMC article. English.
-
Prospective Evaluation of Transsphenoidal Pituitary Surgery in Patients with Cushing's Disease: Delayed Remission and the Role of Postsurgical Cortisol as a Predictive Factor.Healthcare (Basel). 2024 Sep 22;12(18):1900. doi: 10.3390/healthcare12181900. Healthcare (Basel). 2024. PMID: 39337241 Free PMC article.
-
Treatment of recurrent and persistent Cushing's disease after first transsphenoidal surgery: lessons learned from an international meta-analysis.Pituitary. 2022 Jun;25(3):540-549. doi: 10.1007/s11102-022-01215-1. Epub 2022 May 4. Pituitary. 2022. PMID: 35508745
-
Influence of gender and sexual hormones on outcomes after pituitary surgery: a systematic review and meta-analysis.Acta Neurochir (Wien). 2023 Sep;165(9):2445-2460. doi: 10.1007/s00701-023-05726-z. Epub 2023 Aug 9. Acta Neurochir (Wien). 2023. PMID: 37555999 Free PMC article.
-
Lateral one-third gland resection in Cushing patients with failed adenoma identification leads to low remission rates: long-term observations from a small, single-center cohort.Acta Neurochir (Wien). 2021 Nov;163(11):3161-3169. doi: 10.1007/s00701-021-04830-2. Epub 2021 Apr 3. Acta Neurochir (Wien). 2021. PMID: 33811521 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials